Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: single institutional experience.

Caldiroli, M; Cova, V; Lovisolo, J A; Reali, L; Bono, A V

Caldiroli, M; Cova, V; Lovisolo, J A; Reali, L; Bono, A V.

Affiliation

Caldiroli M; Urology Division, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Eur Urol ; 39 Suppl 2: 6-10, 2001 Jan.

Article in En | MEDLINE | ID: mdl-11223689

Subject(s)

Androgen Antagonists/administration & dosage; Prostatic Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local/blood; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2001 Document type: Article Affiliation country: Italy Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links